Membrane-proximal motifs encode differences in signaling strength between type I and III interferon receptors
Interferons (IFNs) play crucial roles in antiviral defenses. Despite using the same Janus-activated kinase (JAK)-signal transducer and activator of transcription (STAT) signaling cascade, type I and III IFN receptors differ in the magnitude and dynamics of their signaling in terms of STAT phosphoryl...
Gespeichert in:
Veröffentlicht in: | Science signaling 2023-10, Vol.16 (806), p.eadf5494-eadf5494 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | eadf5494 |
---|---|
container_issue | 806 |
container_start_page | eadf5494 |
container_title | Science signaling |
container_volume | 16 |
creator | Mesev, Emily V Lin, Aaron E Guare, Emma G Heller, Brigitte L Douam, Florian Adamson, Britt Toettcher, Jared E Ploss, Alexander |
description | Interferons (IFNs) play crucial roles in antiviral defenses. Despite using the same Janus-activated kinase (JAK)-signal transducer and activator of transcription (STAT) signaling cascade, type I and III IFN receptors differ in the magnitude and dynamics of their signaling in terms of STAT phosphorylation, gene transcription, and antiviral responses. These differences are not due to ligand-binding affinity and receptor abundance. Here, we investigated the ability of the intracellular domains (ICDs) of IFN receptors to differentiate between type I and III IFN signaling. We engineered synthetic, heterodimeric type I and III IFN receptors that were stably expressed at similar amounts in human cells and responded to a common ligand. We found that our synthetic type I IFN receptors stimulated STAT phosphorylation and gene expression to greater extents than did the corresponding type III IFN receptors. Furthermore, we identified short "box motifs" within ICDs that bind to JAK1 that were sufficient to encode differences between the type I and III IFN receptors. Together, our results indicate that specific regions within the ICDs of IFN receptor subunits encode different downstream signaling strengths that enable type I and III IFN receptors to produce distinct signaling outcomes. |
doi_str_mv | 10.1126/scisignal.adf5494 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2875852226</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2875852226</sourcerecordid><originalsourceid>FETCH-LOGICAL-c301t-45556f9437b9ae222ef397bbc6ae7a48696b120c427334d4bdbb079893aab67d3</originalsourceid><addsrcrecordid>eNo9kElPwzAQhS0EoqXwA7ggH7mkeHd8RBVLpCIucI7sZFKCsmG7gv57XLVwmkXvvdF8CF1TsqSUqbtQtaHdDLZb2rqRwogTNKeG68xQIU_3vZAZybWeoYsQPglRlDFzjmZc51QRQ-aof4HeeTtANvnxp-1th_sxtk3AMFRjDbhumwZ8GiDgdsCHe-2wwSGm7SZ-YAfxG2DAcTcBLrAdalwURRJH8Mk6DthDBVMcfbhEZ43tAlwd6wK9Pz68rZ6z9etTsbpfZxUnNGZCSqkaI7h2xgJjDBputHOVsqCtyJVRjjJSCaY5F7VwtXNEm9xwa53SNV-g20NueuprCyGWfRsq6Lr06LgNJcu1zGUKVklKD9LKjyF4aMrJJwx-V1JS7imX_5TLI-XkuTnGb10P9b_jDyv_BfjMfYE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2875852226</pqid></control><display><type>article</type><title>Membrane-proximal motifs encode differences in signaling strength between type I and III interferon receptors</title><source>MEDLINE</source><source>Science Magazine</source><creator>Mesev, Emily V ; Lin, Aaron E ; Guare, Emma G ; Heller, Brigitte L ; Douam, Florian ; Adamson, Britt ; Toettcher, Jared E ; Ploss, Alexander</creator><creatorcontrib>Mesev, Emily V ; Lin, Aaron E ; Guare, Emma G ; Heller, Brigitte L ; Douam, Florian ; Adamson, Britt ; Toettcher, Jared E ; Ploss, Alexander</creatorcontrib><description>Interferons (IFNs) play crucial roles in antiviral defenses. Despite using the same Janus-activated kinase (JAK)-signal transducer and activator of transcription (STAT) signaling cascade, type I and III IFN receptors differ in the magnitude and dynamics of their signaling in terms of STAT phosphorylation, gene transcription, and antiviral responses. These differences are not due to ligand-binding affinity and receptor abundance. Here, we investigated the ability of the intracellular domains (ICDs) of IFN receptors to differentiate between type I and III IFN signaling. We engineered synthetic, heterodimeric type I and III IFN receptors that were stably expressed at similar amounts in human cells and responded to a common ligand. We found that our synthetic type I IFN receptors stimulated STAT phosphorylation and gene expression to greater extents than did the corresponding type III IFN receptors. Furthermore, we identified short "box motifs" within ICDs that bind to JAK1 that were sufficient to encode differences between the type I and III IFN receptors. Together, our results indicate that specific regions within the ICDs of IFN receptor subunits encode different downstream signaling strengths that enable type I and III IFN receptors to produce distinct signaling outcomes.</description><identifier>ISSN: 1945-0877</identifier><identifier>EISSN: 1937-9145</identifier><identifier>DOI: 10.1126/scisignal.adf5494</identifier><identifier>PMID: 37816090</identifier><language>eng</language><publisher>United States</publisher><subject>Antiviral Agents - pharmacology ; Humans ; Interferon Type I - genetics ; Interferon Type I - metabolism ; Interferons - metabolism ; Janus Kinases - metabolism ; Ligands ; Phosphorylation ; Receptors, Interferon - genetics ; Receptors, Interferon - metabolism ; Signal Transduction ; STAT1 Transcription Factor - genetics ; STAT1 Transcription Factor - metabolism</subject><ispartof>Science signaling, 2023-10, Vol.16 (806), p.eadf5494-eadf5494</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c301t-45556f9437b9ae222ef397bbc6ae7a48696b120c427334d4bdbb079893aab67d3</citedby><cites>FETCH-LOGICAL-c301t-45556f9437b9ae222ef397bbc6ae7a48696b120c427334d4bdbb079893aab67d3</cites><orcidid>0000-0002-9451-5819 ; 0009-0008-4068-8627 ; 0000-0001-7400-4125 ; 0000-0002-4791-6767 ; 0000-0003-1229-1637 ; 0000-0002-1546-4030 ; 0000-0001-9322-7252</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,2870,2871,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37816090$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mesev, Emily V</creatorcontrib><creatorcontrib>Lin, Aaron E</creatorcontrib><creatorcontrib>Guare, Emma G</creatorcontrib><creatorcontrib>Heller, Brigitte L</creatorcontrib><creatorcontrib>Douam, Florian</creatorcontrib><creatorcontrib>Adamson, Britt</creatorcontrib><creatorcontrib>Toettcher, Jared E</creatorcontrib><creatorcontrib>Ploss, Alexander</creatorcontrib><title>Membrane-proximal motifs encode differences in signaling strength between type I and III interferon receptors</title><title>Science signaling</title><addtitle>Sci Signal</addtitle><description>Interferons (IFNs) play crucial roles in antiviral defenses. Despite using the same Janus-activated kinase (JAK)-signal transducer and activator of transcription (STAT) signaling cascade, type I and III IFN receptors differ in the magnitude and dynamics of their signaling in terms of STAT phosphorylation, gene transcription, and antiviral responses. These differences are not due to ligand-binding affinity and receptor abundance. Here, we investigated the ability of the intracellular domains (ICDs) of IFN receptors to differentiate between type I and III IFN signaling. We engineered synthetic, heterodimeric type I and III IFN receptors that were stably expressed at similar amounts in human cells and responded to a common ligand. We found that our synthetic type I IFN receptors stimulated STAT phosphorylation and gene expression to greater extents than did the corresponding type III IFN receptors. Furthermore, we identified short "box motifs" within ICDs that bind to JAK1 that were sufficient to encode differences between the type I and III IFN receptors. Together, our results indicate that specific regions within the ICDs of IFN receptor subunits encode different downstream signaling strengths that enable type I and III IFN receptors to produce distinct signaling outcomes.</description><subject>Antiviral Agents - pharmacology</subject><subject>Humans</subject><subject>Interferon Type I - genetics</subject><subject>Interferon Type I - metabolism</subject><subject>Interferons - metabolism</subject><subject>Janus Kinases - metabolism</subject><subject>Ligands</subject><subject>Phosphorylation</subject><subject>Receptors, Interferon - genetics</subject><subject>Receptors, Interferon - metabolism</subject><subject>Signal Transduction</subject><subject>STAT1 Transcription Factor - genetics</subject><subject>STAT1 Transcription Factor - metabolism</subject><issn>1945-0877</issn><issn>1937-9145</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kElPwzAQhS0EoqXwA7ggH7mkeHd8RBVLpCIucI7sZFKCsmG7gv57XLVwmkXvvdF8CF1TsqSUqbtQtaHdDLZb2rqRwogTNKeG68xQIU_3vZAZybWeoYsQPglRlDFzjmZc51QRQ-aof4HeeTtANvnxp-1th_sxtk3AMFRjDbhumwZ8GiDgdsCHe-2wwSGm7SZ-YAfxG2DAcTcBLrAdalwURRJH8Mk6DthDBVMcfbhEZ43tAlwd6wK9Pz68rZ6z9etTsbpfZxUnNGZCSqkaI7h2xgJjDBputHOVsqCtyJVRjjJSCaY5F7VwtXNEm9xwa53SNV-g20NueuprCyGWfRsq6Lr06LgNJcu1zGUKVklKD9LKjyF4aMrJJwx-V1JS7imX_5TLI-XkuTnGb10P9b_jDyv_BfjMfYE</recordid><startdate>20231010</startdate><enddate>20231010</enddate><creator>Mesev, Emily V</creator><creator>Lin, Aaron E</creator><creator>Guare, Emma G</creator><creator>Heller, Brigitte L</creator><creator>Douam, Florian</creator><creator>Adamson, Britt</creator><creator>Toettcher, Jared E</creator><creator>Ploss, Alexander</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9451-5819</orcidid><orcidid>https://orcid.org/0009-0008-4068-8627</orcidid><orcidid>https://orcid.org/0000-0001-7400-4125</orcidid><orcidid>https://orcid.org/0000-0002-4791-6767</orcidid><orcidid>https://orcid.org/0000-0003-1229-1637</orcidid><orcidid>https://orcid.org/0000-0002-1546-4030</orcidid><orcidid>https://orcid.org/0000-0001-9322-7252</orcidid></search><sort><creationdate>20231010</creationdate><title>Membrane-proximal motifs encode differences in signaling strength between type I and III interferon receptors</title><author>Mesev, Emily V ; Lin, Aaron E ; Guare, Emma G ; Heller, Brigitte L ; Douam, Florian ; Adamson, Britt ; Toettcher, Jared E ; Ploss, Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c301t-45556f9437b9ae222ef397bbc6ae7a48696b120c427334d4bdbb079893aab67d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antiviral Agents - pharmacology</topic><topic>Humans</topic><topic>Interferon Type I - genetics</topic><topic>Interferon Type I - metabolism</topic><topic>Interferons - metabolism</topic><topic>Janus Kinases - metabolism</topic><topic>Ligands</topic><topic>Phosphorylation</topic><topic>Receptors, Interferon - genetics</topic><topic>Receptors, Interferon - metabolism</topic><topic>Signal Transduction</topic><topic>STAT1 Transcription Factor - genetics</topic><topic>STAT1 Transcription Factor - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mesev, Emily V</creatorcontrib><creatorcontrib>Lin, Aaron E</creatorcontrib><creatorcontrib>Guare, Emma G</creatorcontrib><creatorcontrib>Heller, Brigitte L</creatorcontrib><creatorcontrib>Douam, Florian</creatorcontrib><creatorcontrib>Adamson, Britt</creatorcontrib><creatorcontrib>Toettcher, Jared E</creatorcontrib><creatorcontrib>Ploss, Alexander</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Science signaling</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mesev, Emily V</au><au>Lin, Aaron E</au><au>Guare, Emma G</au><au>Heller, Brigitte L</au><au>Douam, Florian</au><au>Adamson, Britt</au><au>Toettcher, Jared E</au><au>Ploss, Alexander</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Membrane-proximal motifs encode differences in signaling strength between type I and III interferon receptors</atitle><jtitle>Science signaling</jtitle><addtitle>Sci Signal</addtitle><date>2023-10-10</date><risdate>2023</risdate><volume>16</volume><issue>806</issue><spage>eadf5494</spage><epage>eadf5494</epage><pages>eadf5494-eadf5494</pages><issn>1945-0877</issn><eissn>1937-9145</eissn><abstract>Interferons (IFNs) play crucial roles in antiviral defenses. Despite using the same Janus-activated kinase (JAK)-signal transducer and activator of transcription (STAT) signaling cascade, type I and III IFN receptors differ in the magnitude and dynamics of their signaling in terms of STAT phosphorylation, gene transcription, and antiviral responses. These differences are not due to ligand-binding affinity and receptor abundance. Here, we investigated the ability of the intracellular domains (ICDs) of IFN receptors to differentiate between type I and III IFN signaling. We engineered synthetic, heterodimeric type I and III IFN receptors that were stably expressed at similar amounts in human cells and responded to a common ligand. We found that our synthetic type I IFN receptors stimulated STAT phosphorylation and gene expression to greater extents than did the corresponding type III IFN receptors. Furthermore, we identified short "box motifs" within ICDs that bind to JAK1 that were sufficient to encode differences between the type I and III IFN receptors. Together, our results indicate that specific regions within the ICDs of IFN receptor subunits encode different downstream signaling strengths that enable type I and III IFN receptors to produce distinct signaling outcomes.</abstract><cop>United States</cop><pmid>37816090</pmid><doi>10.1126/scisignal.adf5494</doi><orcidid>https://orcid.org/0000-0002-9451-5819</orcidid><orcidid>https://orcid.org/0009-0008-4068-8627</orcidid><orcidid>https://orcid.org/0000-0001-7400-4125</orcidid><orcidid>https://orcid.org/0000-0002-4791-6767</orcidid><orcidid>https://orcid.org/0000-0003-1229-1637</orcidid><orcidid>https://orcid.org/0000-0002-1546-4030</orcidid><orcidid>https://orcid.org/0000-0001-9322-7252</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1945-0877 |
ispartof | Science signaling, 2023-10, Vol.16 (806), p.eadf5494-eadf5494 |
issn | 1945-0877 1937-9145 |
language | eng |
recordid | cdi_proquest_miscellaneous_2875852226 |
source | MEDLINE; Science Magazine |
subjects | Antiviral Agents - pharmacology Humans Interferon Type I - genetics Interferon Type I - metabolism Interferons - metabolism Janus Kinases - metabolism Ligands Phosphorylation Receptors, Interferon - genetics Receptors, Interferon - metabolism Signal Transduction STAT1 Transcription Factor - genetics STAT1 Transcription Factor - metabolism |
title | Membrane-proximal motifs encode differences in signaling strength between type I and III interferon receptors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T16%3A56%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Membrane-proximal%20motifs%20encode%20differences%20in%20signaling%20strength%20between%20type%20I%20and%20III%20interferon%20receptors&rft.jtitle=Science%20signaling&rft.au=Mesev,%20Emily%20V&rft.date=2023-10-10&rft.volume=16&rft.issue=806&rft.spage=eadf5494&rft.epage=eadf5494&rft.pages=eadf5494-eadf5494&rft.issn=1945-0877&rft.eissn=1937-9145&rft_id=info:doi/10.1126/scisignal.adf5494&rft_dat=%3Cproquest_cross%3E2875852226%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2875852226&rft_id=info:pmid/37816090&rfr_iscdi=true |